𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Inhibition of Ehrlich ascites tumor in vivo by PAF-antagonists

✍ Scribed by Denise Fecchio; Momtchilo Russo; Pierre Sirois; Pierre Braquet; Sonia Jancar


Publisher
Elsevier Science
Year
1990
Tongue
English
Weight
738 KB
Volume
12
Category
Article
ISSN
0192-0561

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Phosphate transport in Ehrlich ascites t
✍ Jesse W. Bowen; Charles Levinson πŸ“‚ Article πŸ“… 1986 πŸ› John Wiley and Sons 🌐 English βš– 608 KB

The effect of changes in extracellular pH (pH,) and intracellular pH (pHJ on Na+-dependent and Na+-independent inorganic phosphate (Pi) transport in Ehrlich cells was investigated. In the presence of Na+, acutely reducing pH, from 7.30 to 5.50 results first in a transient (-7 min) stimulation of Pi

Self-inhibition of chloride transport in
✍ Charles Levinson πŸ“‚ Article πŸ“… 1984 πŸ› John Wiley and Sons 🌐 English βš– 803 KB

## Abstract Previous studies have shown that mediated Cl^βˆ’^ transport which occurs by at least two processes (Cl^βˆ’^‐dependent cation cotransport and Cl^βˆ’^ self‐exchange) becomes progressively inhibited when extracellular Cl^βˆ’^ exceeds about 60 mM (Hoffmann et al., 1979). To account for this type of

Paracrine action of sFLT-1 secreted by s
✍ Sunitha Ramachandra; Saritha Sandra D'Souza; Anupama E. Gururaj; Melkote S. Shai πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 441 KB πŸ‘ 1 views

## Abstract ## Background Vascular endothelial growth factor (VEGF) is known to play a major role in angiogenesis. A soluble form of Flt‐1, a VEGF receptor, is potentially useful as an antagonist of VEGF, and accumulating evidence suggests the applicability of sFlt‐1 in tumor suppression. In the p

Inhibition of ex-vivo PAF-induced platel
✍ J. L. Pinquier; P. Sedivy; R. Bruno; F. Bompart; J. Gregoire; G. Strauch; J. Gai πŸ“‚ Article πŸ“… 1991 πŸ› Springer 🌐 English βš– 469 KB

RP 48740, 3-(3-pyridyl)-1H,3H-pyrrolo [1,2-c] thiazole-7-carboxamide, a specific competitive PAF-receptor antagonist in vitro, was given to 29 healthy male volunteers for 7 days. Plasma drug concentrations and ex-vivo PAF-induced platelet aggregation were assessed on Days 1, 4, and 7. RP 48740 had l